Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
should check their graduate program listing in http://www.rackham.umich.edu/programs-of-study . The work described above for this position must be considered academically relevant by the department
-
Compliance shall attend or send a representative to all physical polling locations and places where ballots are kept and tabulated, provided such representative is not a candidate or agent in the election
-
subareas include, but are not limited to: procedural content generation, intelligent non-player characters and agents, adaptive and personalized gameplay, narrative in games, AI for content and/or design
-
● Hourly pay rates range from $38.36 to $54.87 based on experience, with rate increases after 12, 24, and 36 months of service. ● Competitive benefits include a tuition reimbursement program that covers 100
-
-leading expertise in nutrition, food, and plant sciences to discover and deliver innovative plant-based strategies for advancing human health. PHHI is unique in that it supports an in-house outreach
-
. Position Overview Division of Bioinformatics and Computational Biology (DBCB, https://medicine.osu.edu/departments/biomedical-informatics/divisions/division-of-bioinformatics-and-computational-biology
-
offer components are subject to additional approvals based on UC policy. Your placement within the salary range is dependent on a number of factors including your work experience and internal equity
-
, develop and execute workshops and projects based on direction, needs, and input from the committee. This GSSA position is ideal for those who are interested in needs assessment, program development
-
, evidence-based treatment plans in dynamic critical care environments. Prescribes and titrates pharmacologic agents (including vasoactive infusions / vasopressors, sedatives, analgesics, paralytics
-
to cancer therapeutics, target identification, mechanism-based pharmacology, or chemoprevention. We have a special interest in candidates focused on the development of novel agents for cancer-associated pain